143 related articles for article (PubMed ID: 10804029)
1. The intracellular target for the antiresorptive aminobisphosphonate drugs in Dictyostelium discoideum is the enzyme farnesyl diphosphate synthase.
Grove JE; Brown RJ; Watts DJ
J Bone Miner Res; 2000 May; 15(5):971-81. PubMed ID: 10804029
[TBL] [Abstract][Full Text] [Related]
2. Engineered gene over-expression as a method of drug target identification.
Sugden CJ; Roper JR; Williams JG
Biochem Biophys Res Commun; 2005 Aug; 334(2):555-60. PubMed ID: 16005849
[TBL] [Abstract][Full Text] [Related]
3. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G
Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
[TBL] [Abstract][Full Text] [Related]
5. Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase.
Thompson K; Dunford JE; Ebetino FH; Rogers MJ
Biochem Biophys Res Commun; 2002 Jan; 290(2):869-73. PubMed ID: 11785983
[TBL] [Abstract][Full Text] [Related]
6. Farnesyl diphosphate synthase is a cytosolic enzyme in Leishmania major promastigotes and its overexpression confers resistance to risedronate.
Ortiz-Gómez A; Jiménez C; Estévez AM; Carrero-Lérida J; Ruiz-Pérez LM; González-Pacanowska D
Eukaryot Cell; 2006 Jul; 5(7):1057-64. PubMed ID: 16835450
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway.
Fisher JE; Rodan GA; Reszka AA
Endocrinology; 2000 Dec; 141(12):4793-6. PubMed ID: 11108295
[TBL] [Abstract][Full Text] [Related]
8. Farnesyl diphosphate synthase, the target for nitrogen-containing bisphosphonate drugs, is a peroxisomal enzyme in the model system Dictyostelium discoideum.
Nuttall JM; Hettema EH; Watts DJ
Biochem J; 2012 Nov; 447(3):353-61. PubMed ID: 22849378
[TBL] [Abstract][Full Text] [Related]
9. Determination of the microscopic equilibrium dissociation constants for risedronate and its analogues reveals two distinct roles for the nitrogen atom in nitrogen-containing bisphosphonate drugs.
Hounslow AM; Carran J; Brown RJ; Rejman D; Blackburn GM; Watts DJ
J Med Chem; 2008 Jul; 51(14):4170-8. PubMed ID: 18590315
[TBL] [Abstract][Full Text] [Related]
10. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
Stresing V; Fournier PG; Bellahcène A; Benzaïd I; Mönkkönen H; Colombel M; Ebetino FH; Castronovo V; Clézardin P
Bone; 2011 Feb; 48(2):259-66. PubMed ID: 20920623
[TBL] [Abstract][Full Text] [Related]
11. The regulation of activity of main mevalonic acid pathway enzymes: farnesyl diphosphate synthase, 3-hydroxy-3-methylglutaryl-CoA reductase, and squalene synthase in yeast Saccharomyces cerevisiae.
Szkopińska A; Swiezewska E; Karst F
Biochem Biophys Res Commun; 2000 Jan; 267(1):473-7. PubMed ID: 10623644
[TBL] [Abstract][Full Text] [Related]
12. Farnesyl diphosphate synthase; regulation of product specificity.
Szkopińska A; Płochocka D
Acta Biochim Pol; 2005; 52(1):45-55. PubMed ID: 15827605
[TBL] [Abstract][Full Text] [Related]
13. Nitrogen-containing bisphosphonate mechanism of action.
Reszka AA; Rodan GA
Mini Rev Med Chem; 2004 Sep; 4(7):711-9. PubMed ID: 15379639
[TBL] [Abstract][Full Text] [Related]
14. Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.
Sanders JM; Song Y; Chan JM; Zhang Y; Jennings S; Kosztowski T; Odeh S; Flessner R; Schwerdtfeger C; Kotsikorou E; Meints GA; Gómez AO; González-Pacanowska D; Raker AM; Wang H; van Beek ER; Papapoulos SE; Morita CT; Oldfield E
J Med Chem; 2005 Apr; 48(8):2957-63. PubMed ID: 15828834
[TBL] [Abstract][Full Text] [Related]
15. Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design.
Gabelli SB; McLellan JS; Montalvetti A; Oldfield E; Docampo R; Amzel LM
Proteins; 2006 Jan; 62(1):80-8. PubMed ID: 16288456
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide sequence of alkyl-dihydroxyacetonephosphate synthase cDNA from Dictyostelium discoideum.
de Vet EC; van den Bosch H
Biochem Biophys Res Commun; 1998 Nov; 252(3):629-33. PubMed ID: 9837757
[TBL] [Abstract][Full Text] [Related]
17. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
David P; Nguyen H; Barbier A; Baron R
J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum.
Brown RJ; van Beek E; Watts DJ; Löwik CW; Papapoulos SE
J Bone Miner Res; 1998 Feb; 13(2):253-8. PubMed ID: 9495518
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of squalene synthase from the green microalga Botryococcus braunii, race B.
Okada S; Devarenne TP; Chappell J
Arch Biochem Biophys; 2000 Jan; 373(2):307-17. PubMed ID: 10620354
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of squalene synthase (SQS) gene from Ganoderma lucidum.
Zhao MW; Liang WQ; Zhang DB; Wang N; Wang CG; Pan YJ
J Microbiol Biotechnol; 2007 Jul; 17(7):1106-12. PubMed ID: 18051320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
